LC-ESI-MS/MS method validation for simultaneous quantification of FDA-approved anticancer agents futibatinib and binimetinib in rat plasma: Insights from preclinical pharmacokinetics.
Saved in:
| Title: | LC-ESI-MS/MS method validation for simultaneous quantification of FDA-approved anticancer agents futibatinib and binimetinib in rat plasma: Insights from preclinical pharmacokinetics. |
|---|---|
| Authors: | Dadge SD; Pharmaceutics & Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow, 226031, India.; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India., Yadav S; Pharmaceutics & Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow, 226031, India.; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India., Rathaur S; Pharmaceutics & Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow, 226031, India., Gayen JR; Pharmaceutics & Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow, 226031, India.; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.; Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, 226031, India. |
| Source: | Biomedical chromatography : BMC [Biomed Chromatogr] 2024 Nov; Vol. 38 (11), pp. e6005. Date of Electronic Publication: 2024 Sep 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 8610241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-0801 (Electronic) Linking ISSN: 02693879 NLM ISO Abbreviation: Biomed Chromatogr Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1099-0801 |
|---|---|
| DOI: | 10.1002/bmc.6005 |
